Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use

Stratify and ImmunoWELL JCV tests performances in a real-world multiple sclerosis cohort: possible clinical implications of biosimilar Natalizumab use / Guerrieri, S., Gattuso, I., Genchi, A., Nozzolillo, A., Viti, V., Zanetta, C., D'Amore, G., Rocca, M.A., Moiola, L., Filippi, M.. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 272:9(2025). [10.1007/s00415-025-13273-z]